Kardigan’s IPO haul has come in 14% above expectations, grossing $400 million after the cardiovascular disease biotech upsized the offering and hit the top end of its target range.
发布时间
2026-06-20
区域
Global
语言
en
同一行业内按时间和重要性排序的相邻信号，用于判断该事件是否正在形成连续动量。
Medical device maker iRhythm has been hit by a cyberattack, but the company said the incident has not affected its core products, operations or ability to meet patient needs.
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.
AI drug design specialist Protillion has inked a $510 million biobucks collaboration and license agreement with Merck & Co. that brings together Protillion’s platform and Merck’s drug discovery expertise.
Adaptive Biotechnologies is planning to separate its drug discovery and diagnostics businesses, outlining its intent to evaluate “strategic and structural alternatives” for the medicine wing of the company
该信号所在行业的最新 TrendSummary，用于把单条事件放回周期性判断中。
生物科技关注点从平台叙事回到临床进展、可制造性和监管沟通，资本更看重里程碑兑现。
建议关注临床里程碑、自动化生产设备订单和合成生物材料的吨级成本曲线。
蛋白设计
volume 5,600 / growth +2.7%